Ident. | Authors (with country if any) | Title |
---|
000010 (2021) |
Nicole Fagan [Irlande (pays)] ; Nekma Meah [Australie] ; Katherine York [Afrique du Sud] ; Laita Bokhari [Australie] ; Godfrey Fletcher [Irlande (pays)] ; Gang Chen [Australie] ; Desmond J. Tobin [Irlande (pays)] ; Andrew Messenger [Royaume-Uni] ; Alan D. Irvine [Irlande (pays)] ; Rodney Sinclair [Australie] ; Dmitri Wall [Irlande (pays)] | Shedding light on therapeutics in alopecia and their relevance to COVID-19. |
000099 (2021) |
Zelyn Lee [Canada] ; Craig R. Rayner [États-Unis, Australie] ; Jamie I. Forrest [Canada] ; Jean B. Nachega [Afrique du Sud, États-Unis, Canada] ; Esha Senchaudhuri [Canada] ; Edward J. Mills [Canada] | The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19. |
000128 (2021) |
Deepak Mishra [Inde] ; Radha Raman Maurya [Inde] ; Kamlesh Kumar [Inde] ; Nupur S. Munjal [Inde] ; Vijay Bahadur [Inde] ; Sandeep Sharma [Inde] ; Prashant Singh [Inde] ; Indra Bahadur [Afrique du Sud] | Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies. |
000203 (2021) |
F O Shode [Afrique du Sud] ; A S K. Idowu [Afrique du Sud] ; O J Uhomoibhi [Afrique du Sud] ; S. Sabiu [Afrique du Sud] | Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2. |
000306 (2021) |
Pobitra Borah [Inde] ; Pran Kishore Deb [Jordanie] ; Balakumar Chandrasekaran [Jordanie] ; Manoj Goyal [Arabie saoudite] ; Monika Bansal [Arabie saoudite] ; Snawar Hussain [Arabie saoudite] ; Pottathil Shinu [Arabie saoudite] ; Katharigatta N. Venugopala [Afrique du Sud] ; Nizar A. Al-Shar'I [Jordanie] ; Satyendra Deka [Inde] ; Vinayak Singh [Afrique du Sud] | Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted. |
000311 (2021) |
Aitebiremen Gift Omokhua-Uyi [Afrique du Sud] ; Johannes Van Staden [Afrique du Sud] | Natural product remedies for COVID-19: A focus on safety. |
000349 (2021) |
Gaber El-Saber Batiha [Égypte] ; Marwa A. Zayed [Égypte] ; Aya A. Awad [Égypte] ; Hazem M. Shaheen [Égypte] ; Suleiman Mustapha [Nigeria] ; Oscar Herrera-Calderon [Pérou] ; Jorge Pamplona Pagnossa [Brésil] ; Abdelazeem M. Algammal [Égypte] ; Muhammad Zahoor [Pakistan] ; Achyut Adhikari [Népal] ; Ishan Pandey [Inde] ; Sara T. Elazab [Égypte] ; Kannan R R. Rengasamy [Afrique du Sud] ; Natália Cruz-Martins [Portugal] ; Helal F. Hetta [Égypte] | Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19. |
000481 (2021) |
Razieh Morad [Afrique du Sud] ; Mahmood Akbari [Afrique du Sud] ; Parham Rezaee [Iran] ; Amin Koochaki [Iran] ; Malik Maaza [Afrique du Sud] ; Zahra Jamshidi [Iran] | First principle simulation of coated hydroxychloroquine on Ag, Au and Pt nanoparticles. |
000548 (2021) |
Andrea Giacomelli [Italie] ; Gabriele Pagani [Italie] ; Anna L. Ridolfo [Italie] ; Letizia Oreni [Italie] ; Federico Conti [Italie] ; Laura Pezzati [Italie] ; Lucia Bradanini [Italie] ; Giacomo Casalini [Italie] ; Cinzia Bassoli [Italie] ; Valentina Morena [Italie] ; Simone Passerini [Italie] ; Giuliano Rizzardini [Italie, Afrique du Sud] ; Chiara Cogliati [Italie] ; Elisa Ceriani [Italie] ; Riccardo Colombo [Italie] ; Stefano Rusconi [Italie] ; Cristina Gervasoni [Italie] ; Dario Cattaneo [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie] | Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. |
000633 (2021) |
Bhagteshwar Singh [Royaume-Uni, Inde] ; Hannah Ryan [Royaume-Uni] ; Tamara Kredo [Afrique du Sud] ; Marty Chaplin [Royaume-Uni] ; Tom Fletcher [Royaume-Uni] | Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. |
000770 (2021) |
François Lamontagne [Canada] ; Thomas Agoritsas [Suisse, Canada, Norvège] ; Reed Siemieniuk [Canada] ; Bram Rochwerg [Canada] ; Jessica Bartoszko [Canada] ; Lisa Askie [Suisse] ; Helen Macdonald [Royaume-Uni] ; Wagdy Amin [Égypte] ; Frederique Jacquerioz Bausch [Suisse] ; Erlina Burhan ; Maurizio Cecconi [Italie] ; Duncan Chanda [Zambie] ; Vu Quoc Dat [Viêt Nam] ; Bin Du [République populaire de Chine] ; Heike Geduld [Afrique du Sud] ; Patrick Gee [États-Unis] ; Harley Nerina [Australie] ; Madiha Hashimi [Pakistan] ; Beverley J. Hunt [Royaume-Uni] ; Sushil Kabra [Inde] ; Seema Kanda [Canada] ; Leticia Kawano-Dourado [Brésil] ; Yae-Jean Kim [Corée du Sud] ; Niranjan Kissoon [Canada] ; Arthur Kwizera [Ouganda] ; Yee-Sin Leo [Singapour] ; Imelda Mahaka [Zimbabwe] ; Hela Manai [Tunisie] ; Greta Mino [Équateur] ; Emmanuel Nsutebu ; Natalia Pshenichnaya [Russie] ; Nida Qadir [États-Unis] ; Shalini Sri Ranganathan [Sri Lanka] ; Saniya Sabzwari [Pakistan] ; Rohit Sarin [Inde] ; Michael Sharland [Royaume-Uni] ; Yinzhong Shen [République populaire de Chine] ; Joao Paulo Souza [Brésil] ; Miriam Stegemann [Allemagne] ; Sebastian Ugarte [Chili] ; Sridhar Venkatapuram [Royaume-Uni] ; Dubula Vuyiseka [Afrique du Sud] ; Jacobus Preller [Suisse] ; Romina Brignardello-Petersen [Canada] ; Elena Kum [Canada] ; Anila Qasim [Canada] ; Dena Zeraatkar [Canada] ; Andrew Owen [Royaume-Uni] ; Gordon Guyatt [Canada] ; Lyubov Lytvyn [Canada] ; Janet Diaz [Suisse] ; Per Olav Vandvik [Norvège] ; Michael Jacobs [Canada] | A living WHO guideline on drugs to prevent covid-19. |
000A59 (2020) |
Junaed Younus Khan [Bangladesh] ; Md Tawkat Islam Khondaker [Bangladesh] ; Iram Tazim Hoque [Bangladesh] ; Hamada R H. Al-Absi [Qatar] ; Mohammad Saifur Rahman [Bangladesh] ; Reto Guler [Afrique du Sud] ; Tanvir Alam [Qatar] ; M Sohel Rahman [Bangladesh] | Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach. |
000B85 (2020) |
Sebastian E. Sattui [États-Unis] ; Jean W. Liew [États-Unis] ; Elizabeth R. Graef [États-Unis] ; Ariella Coler-Reilly [États-Unis] ; Francis Berenbaum [France] ; Alí Duarte-García [États-Unis] ; Carly Harrison [États-Unis] ; Maximilian F. Konig [États-Unis] ; Peter Korsten [Allemagne] ; Michael S. Putman [États-Unis] ; Philip C. Robinson [Australie] ; Emily Sirotich [Canada] ; Manuel F. Ugarte-Gil [Pérou] ; Kate Webb [Afrique du Sud, Royaume-Uni] ; Kristen J. Young [États-Unis] ; Alfred H J. Kim [États-Unis] ; Jeffrey A. Sparks [États-Unis] | Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. |
000D70 (2020) |
Israel Abebrese Sefah [Ghana] ; Olayinka O. Ogunleye [Nigeria] ; Darius Obeng Essah [Ghana] ; Sylvia A. Opanga [Kenya] ; Nadia Butt [Kenya] ; Annie Wamaitha [Kenya] ; Anastasia Nkatha Guantai [Kenya] ; Ibrahim Chikowe [Malawi] ; Felix Khuluza [Malawi] ; Dan Kibuule [Namibie] ; Lahya Nambahu [Namibie] ; Abdullahi Rabiu Abubakar [Nigeria] ; Ibrahim Haruna Sani [Nigeria] ; Zikria Saleem [Pakistan] ; Aubrey C. Kalungia [Zambie] ; Thuy Nguyen Thi Phuong [Viêt Nam] ; Mainul Haque [Malaisie] ; Salequl Islam [Bangladesh] ; Santosh Kumar [Inde] ; Jacqueline Sneddon [Royaume-Uni] ; Joshua Wamboga [Ouganda] ; Janney Wale [Australie] ; Nenad Miljkovi [Serbie] ; Amanj Kurdi [Royaume-Uni, Iraq] ; Antony P. Martin [Royaume-Uni] ; Brian Godman [Royaume-Uni, Afrique du Sud, Malaisie, Suède] | Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications. |
000D71 (2020) |
Brian Godman [Royaume-Uni, Suède, Afrique du Sud, Malaisie] ; Mainul Haque [Malaisie] ; Salequl Islam [Bangladesh] ; Samiul Iqbal [Bangladesh] ; Umme Laila Urmi [Bangladesh] ; Zubair Mahmood Kamal [États-Unis] ; Shahriar Ahmed Shuvo [Bangladesh] ; Aminur Rahman [Bangladesh] ; Mustafa Kamal [Bangladesh] ; Monami Haque [Bangladesh] ; Iffat Jahan [Bangladesh] ; Md Zakirul Islam [Bangladesh] ; Mohammad Monir Hossain [Bangladesh] ; Munzur-E-Murshid [Bangladesh] ; Santosh Kumar [Inde] ; Jaykaran Charan [Inde] ; Rohan Bhatt [Inde] ; Siddhartha Dutta [Inde] ; Jha Pallavi Abhayanand [Inde] ; Yesh Sharma [Inde] ; Zikria Saleem [Pakistan] ; Thuy Nguyen Thi Phuong [Viêt Nam] ; Hye-Young Kwon [Royaume-Uni, Corée du Sud] ; Amanj Kurdi [Royaume-Uni, Iraq] ; Janney Wale [Australie] ; Israel Sefah [Ghana] | Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future. |
000F20 (2020) |
Fatemeh Oroojalian [Iran] ; Ali Haghbin [Iran] ; Behzad Baradaran [Iran] ; Nima Hemmat [Iran] ; Mohammad-Ali Shahbazi [Iran] ; Hossein Bannazadeh Baghi [Iran] ; Ahad Mokhtarzadeh [Iran] ; Michael R. Hamblin [Afrique du Sud] | Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials. |
000F38 (2020) |
Bridget Hodkinson [Afrique du Sud] ; Prasun Singh [Afrique du Sud] ; Ayanda Gcelu [Afrique du Sud] ; Wilson Bautista-Molano [Colombie] ; Guillermo Pons-Estel [Argentine] ; Deshiré Alpízar-Rodríguez [Mexique] | Navigating COVID-19 in the developing world. |
000F39 (2020) |
Joyce Oloaigbe Ogidigo [Nigeria] ; Emmanuel A. Iwuchukwu [Afrique du Sud] ; Collins U. Ibeji [Afrique du Sud, Nigeria] ; Okiemute Okpalefe [Nigeria] ; Mahmoud E S. Soliman [Afrique du Sud] | Natural phyto, compounds as possible noncovalent inhibitors against SARS-CoV2 protease: computational approach. |
001208 (2020) |
Michael S. Avidan [États-Unis] ; Hakim-Moulay Dehbi [Royaume-Uni] ; Sinead Delany-Moretlwe [Afrique du Sud] | Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. |
001501 (2020) |
Peter Yamoah [Ghana, Afrique du Sud] ; Thelma Mpoku Alalbila [Ghana] ; Varsha Bangalee [Afrique du Sud] ; Frasia Oosthuizen [Afrique du Sud] | Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion. |
001547 (2020) |
Stephane Picot [France] ; Aileen Marty [États-Unis] ; Anne-Lise Bienvenu [France] ; Lucille H. Blumberg [Afrique du Sud] ; Jean Dupouy-Camet [France] ; Pierre Carnevale [France] ; Shigeyuki Kano [Japon] ; Malcolm K. Jones [Australie] ; Cláudio Tadeu Daniel-Ribeiro [Brésil] ; Santiago Mas-Coma [Espagne] | Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19. |